Welcome to our dedicated page for LHAA news (Ticker: LHAA), a resource for investors and traders seeking the latest updates and insights on LHAA stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LHAA's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LHAA's position in the market.
Lerer Hippeau Acquisition Corp. has priced its initial public offering (IPO) at $10.00 per share, aiming to raise gross proceeds of $200 million through the offering of 20 million shares. The underwriters have a 45-day option for an additional 3 million shares. The shares will trade under the symbol 'LHAA' starting March 5, 2021, with the offering expected to close on March 9, 2021. The company is a blank check firm formed for mergers or acquisitions and is sponsored by Lerer Hippeau, a venture capital firm with over 400 companies in its portfolio.
FAQ
What is the market cap of LHAA (LHAA)?
